Aditxt (ADTX) Accumulated Expenses (2023 - 2026)

Aditxt (ADTX) recorded quarterly Accumulated Expenses of $189084.0 in Q1 2026, down 36.98% quarter-over-quarter from $300041.0 in Q4 2025, and up 2105.32% on a YoY basis from $8574.0 in Q1 2025.

Aditxt (ADTX) Accumulated Expenses (2023 - 2026) Analysis & Trends

Aditxt's Accumulated Expenses history runs 4 years deep, the most recent figure standing at $189084.0 for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 2105.32% year-over-year to $189084.0; the TTM figure through Mar 2026 stood at $189084.0 (up 2105.32% YoY), while the FY2025 annual figure was $300041.0, down 73.45% from the prior year.
  • Accumulated Expenses was $189084.0 for Q1 2026 at Aditxt, down from $300041.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.1 million in Q4 2024 to a low of $8574.0 in Q1 2025.
  • Historically, Accumulated Expenses has averaged $426258.9 across 4 years, with a median of $300041.0 in 2025.
  • The sharpest annual moves came in 2025 and 2026: Accumulated Expenses slumped 73.45% in 2025, then soared 2105.32% in 2026.
  • A 4-year view of Accumulated Expenses shows it stood at $387692.0 in 2023, then jumped by 191.52% to $1.1 million in 2024, then plunged by 73.45% to $300041.0 in 2025, then slumped by 36.98% to $189084.0 in 2026.
  • The last three Accumulated Expenses figures came in at $189084.0 (Q1 2026), $300041.0 (Q4 2025), and $734601.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00

Historic Data

Download Data
DateValue
Mar 31, 2026 189,084.00
Dec 31, 2025 300,041.00
Sep 30, 2025 734,601.00
Jun 30, 2025 233,639.00
Mar 31, 2025 8,574.00
Dec 31, 2024 1.13 Mn
Dec 31, 2023 387,692.00